Document is current
Any future updates will be listed below
-
Authors
Chih, Yu-Chan https://orcid.org/0000-0001-7332-0740
Dietsch, Amelie C.
Koopmann, Philipp
Ma, Xiujian
Agardy, Dennis A. https://orcid.org/0000-0001-6900-2504
Zhao, Binghao
De Roia, Alice
Kourtesakis, Alexandros
Kilian, Michael https://orcid.org/0000-0002-1946-3174
Krämer, Christopher
Suwala, Abigail K.
Stenzinger, Miriam
Boenig, Halvard
Blum, Agnieszka
Pienkowski, Victor Murcia
Aman, Kuralay
Becker, Jonas P. https://orcid.org/0000-0002-1594-9652
Feldmann, Henrike https://orcid.org/0009-0002-5078-6403
Bunse, Theresa https://orcid.org/0000-0003-1834-4269
Harbottle, Richard https://orcid.org/0000-0002-3332-8024
Riemer, Angelika B. https://orcid.org/0000-0002-5865-0714
Liu, Hai-Kun https://orcid.org/0000-0003-3338-4066
Etminan, Nima
Sahm, Felix https://orcid.org/0000-0001-5441-1962
Ratliff, Miriam https://orcid.org/0000-0002-9464-6544
Wick, Wolfgang https://orcid.org/0000-0002-6171-634X
Platten, Michael https://orcid.org/0000-0002-4746-887X
Green, Edward W. https://orcid.org/0000-0003-1922-2298
Bunse, Lukas https://orcid.org/0000-0002-4490-7574
- License Information
-
More Information
Article History
Received: 26 July 2024
Accepted: 20 January 2025
First Online: 1 February 2025
Competing interests
: The identified reactive TCR was patented by Y-C.C., M.K., C.K., E.W.G., W.W., M.P. and L.B., “T cell receptor derived binding polypeptides” (WO 2023/213904). E.W.G. and M.P. are founders of TCellTech. The remaining authors declare no competing interests.
